Market Overview

UPDATE: Stifel Nicolaus Initiates Henry Schein at Hold on Valuation

Share:
Related HSIC
Top 4 NASDAQ Stocks In The Medical Equipment Wholesale Industry With The Highest ROA
UPDATE: Credit Suisse Reiterates On Henry Schein Following 3Q14 Earnings Results
Will Cardinal Health (CAH) Surprise Earnings This Season? - Analyst Blog (Zacks)

Stifel Nicolaus initiated coverage on Henry Schein (NASDAQ: HSIC) with a Hold rating.

Stifel Nicolaus commented, "Henry Schein's market share gains in N.A. dental and veterinary have outpaced that of Patterson, the company's biggest competitor. As a result, we believe Schein's premium valuation is well deserved. That said, for the stock to post 20% upside from current levels, Henry Schein would need to recapture a 20x NTM EPS multiple. The stock's peak multiple over the past three years is in the high teens."

Henry Schein closed at $82.23 on Wednesday.

Latest Ratings for HSIC

DateFirmActionFromTo
Nov 2014Credit SuisseMaintainsNeutral
Nov 2014JP MorganMaintainsNeutral
Nov 2014Credit SuisseMaintainsNeutral

View More Analyst Ratings for HSIC
View the Latest Analyst Ratings

Posted-In: Stifel NicolausAnalyst Color Initiation Intraday Update Analyst Ratings

 

Related Articles (HSIC)

Around the Web, We're Loving...

Get Benzinga's Newsletters